top of page
IP Portfolio Summary
Sangui Bio has a strong and broad patent portfolio, that is managed by the legal and patent firm – Spruson and Ferguson. The portfolio comprises three patent applications currently undergoing national phase examination based on recent discoveries in red blood cell biology and one provisional application. The first PCT application published in April 2017 and has been granted in four jurisdictions.
Blood preparation and profiling (WO2017059477A1)
Therapeutic methods using erythrocytes (WO2017106899A2)
Karsten E, Herbert B, Liddle A, Hill C. Therapeutic methods using erythrocytes. Priority date: 2015-12-22. Stage: National phase examination.
Blood profiling with protease inhibitors (WO2018112500A1)
bottom of page